Join to view full profile
10666 N Torrey Pines RdLa Jolla, CA 92037
Phone+1 858-554-8632
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Andrey, MD is an oncologist in La Jolla, California. He is currently licensed to practice medicine in California, Georgia, and Illinois.
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997- Loyola University Medical CenterResidency, Internal Medicine, 1991 - 1994
Loyola University Chicago Stritch School of MedicineClass of 1991- Loyola University Chicago Stritch School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1997 - 2027
IL State Medical License 1991 - 2002- IL State Medical License 1991 - 2002
GA State Medical License 1997 - 1997
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification MEDSEEK Empower, SymphonyCare, LLC, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014-2017
Publications & Presentations
PubMed
- 49 citationsTransplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.Marcelo C. Pasquini, Júlio César Voltarelli, Harold L. Atkins, Nelson Hamerschlak, Xiaobo Zhong
Biology of Blood and Marrow Transplantation. 2012-10-01 - 5 citationsPurification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia.Florent M. Martin, Josef T. Prchal, Jorge Nieva, Alan Saven, Jeffrey Andrey
British Journal of Haematology. 2008-11-01 - 92 citationsPhase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non–Hodgkin's LymphomaJohn P. Leonard, Brian K. Link, Christos Emmanouilides, Stephanie A. Gregory, Daniel J. Weisdorf
Clinical Cancer Research. 2007-10-15
Press Mentions
Jeffrey Andrey, M.D. Joins the Oncology Institute of Hope and InnovationJune 5th, 2019
